Acute Urinary Retention After I-125 Prostate Brachytherapy in Relation to Dose in Different Regions of the Prostate

The risk of AUR is not associated with dose delivered to different regions of the prostate. However, a higher dose to the bladder neck and a larger extent of prostate protrusion into the bladder are risk factors for the development of AUR after I-125 prostate brachytherapy.